CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000DJ1CUB5

Delayed Deutsche Boerse AG 07:34:23 2024-05-23 EDT
51.57 EUR -0.50% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+5.00%
1 month+6.78%
Date Price Change
24-05-23 51.57 -0.50%
24-05-22 51.83 -1.56%
24-05-21 52.65 -1.05%
24-05-20 53.21 +0.30%
24-05-17 53.05 +0.38%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 07:34 am

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ1CUB
ISINDE000DJ1CUB5
Date issued 2023-04-27
Strike 60
Maturity 2024-12-20 (211 Days)
Parity 1 : 1
Emission price 45.03
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 53.44
Lowest since issue 33.15
Spread 0.02
Spread %0.04%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.75 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.82%
Consensus